Annual EBIT
-$9.94 M
+$4.93 M+33.17%
April 30, 2024
Summary
- As of February 25, 2025, ALZN annual earnings before interest & taxes is -$9.94 million, with the most recent change of +$4.93 million (+33.17%) on April 30, 2024.
- During the last 3 years, ALZN annual EBIT has fallen by -$5.05 million (-103.31%).
- ALZN annual EBIT is now -125.33% below its all-time high of -$4.41 million, reached on April 30, 2020.
Performance
ALZN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.36 M
-$395.70 K-41.12%
October 31, 2024
Summary
- As of February 25, 2025, ALZN quarterly earnings before interest & taxes is -$1.36 million, with the most recent change of -$395.70 thousand (-41.12%) on October 31, 2024.
- Over the past year, ALZN quarterly EBIT has dropped by -$395.70 thousand (-41.12%).
- ALZN quarterly EBIT is now -59.76% below its all-time high of -$850.10 thousand, reached on April 30, 2024.
Performance
ALZN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$5.83 M
+$1.54 M+20.93%
October 31, 2024
Summary
- As of February 25, 2025, ALZN TTM earnings before interest & taxes is -$5.83 million, with the most recent change of +$1.54 million (+20.93%) on October 31, 2024.
- Over the past year, ALZN TTM EBIT has increased by +$1.54 million (+20.93%).
- ALZN TTM EBIT is now -363.92% below its all-time high of -$1.26 million, reached on April 30, 2020.
Performance
ALZN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ALZN EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +33.2% | -41.1% | +20.9% |
3 y3 years | -103.3% | -41.1% | +20.9% |
5 y5 years | -98.4% | -41.1% | +20.9% |
ALZN EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -103.3% | +33.2% | -59.8% | +75.0% | at high | +62.2% |
5 y | 5-year | -125.3% | +33.2% | -59.8% | +75.0% | -363.9% | +62.2% |
alltime | all time | -125.3% | +33.2% | -59.8% | +75.0% | -363.9% | +62.2% |
Alzamend Neuro EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Oct 2024 | - | -$1.36 M(+41.1%) | -$5.83 M(-20.9%) |
Jul 2024 | - | -$962.40 K(+13.2%) | -$7.37 M(-25.8%) |
Apr 2024 | -$9.94 M(-33.2%) | -$850.10 K(-68.0%) | -$9.94 M(-19.8%) |
Jan 2024 | - | -$2.66 M(-8.3%) | -$12.39 M(-18.2%) |
Oct 2023 | - | -$2.90 M(-17.7%) | -$15.16 M(-1.3%) |
Jul 2023 | - | -$3.53 M(+6.7%) | -$15.36 M(+3.3%) |
Apr 2023 | -$14.87 M(+20.7%) | -$3.31 M(-39.1%) | -$14.87 M(-3.7%) |
Jan 2023 | - | -$5.42 M(+74.6%) | -$15.43 M(+22.8%) |
Oct 2022 | - | -$3.11 M(+2.3%) | -$12.57 M(-3.7%) |
Jul 2022 | - | -$3.04 M(-21.5%) | -$13.04 M(+5.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Apr 2022 | -$12.32 M(+152.0%) | -$3.87 M(+51.3%) | -$12.32 M(+27.4%) |
Jan 2022 | - | -$2.56 M(-28.7%) | -$9.67 M(+18.4%) |
Oct 2021 | - | -$3.58 M(+55.4%) | -$8.16 M(+38.9%) |
Jul 2021 | - | -$2.31 M(+89.0%) | -$5.88 M(+20.2%) |
Apr 2021 | -$4.89 M(+10.8%) | -$1.22 M(+15.8%) | -$4.89 M(-0.7%) |
Jan 2021 | - | -$1.05 M(-18.9%) | -$4.92 M(+27.2%) |
Oct 2020 | - | -$1.30 M(-1.4%) | -$3.87 M(+50.4%) |
Jul 2020 | - | -$1.32 M(+4.8%) | -$2.57 M(+104.8%) |
Apr 2020 | -$4.41 M(-12.0%) | -$1.26 M | -$1.26 M |
Apr 2019 | -$5.01 M | - | - |
FAQ
- What is Alzamend Neuro annual earnings before interest & taxes?
- What is the all time high annual EBIT for Alzamend Neuro?
- What is Alzamend Neuro annual EBIT year-on-year change?
- What is Alzamend Neuro quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Alzamend Neuro?
- What is Alzamend Neuro quarterly EBIT year-on-year change?
- What is Alzamend Neuro TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Alzamend Neuro?
- What is Alzamend Neuro TTM EBIT year-on-year change?
What is Alzamend Neuro annual earnings before interest & taxes?
The current annual EBIT of ALZN is -$9.94 M
What is the all time high annual EBIT for Alzamend Neuro?
Alzamend Neuro all-time high annual earnings before interest & taxes is -$4.41 M
What is Alzamend Neuro annual EBIT year-on-year change?
Over the past year, ALZN annual earnings before interest & taxes has changed by +$4.93 M (+33.17%)
What is Alzamend Neuro quarterly earnings before interest & taxes?
The current quarterly EBIT of ALZN is -$1.36 M
What is the all time high quarterly EBIT for Alzamend Neuro?
Alzamend Neuro all-time high quarterly earnings before interest & taxes is -$850.10 K
What is Alzamend Neuro quarterly EBIT year-on-year change?
Over the past year, ALZN quarterly earnings before interest & taxes has changed by -$395.70 K (-41.12%)
What is Alzamend Neuro TTM earnings before interest & taxes?
The current TTM EBIT of ALZN is -$5.83 M
What is the all time high TTM EBIT for Alzamend Neuro?
Alzamend Neuro all-time high TTM earnings before interest & taxes is -$1.26 M
What is Alzamend Neuro TTM EBIT year-on-year change?
Over the past year, ALZN TTM earnings before interest & taxes has changed by +$1.54 M (+20.93%)